Bristol Myers Squibb Co  (BMY)
Other Ticker:  
Price: $64.4400 $-0.02 -0.031%
Day's High: $65.39 Week Perf: 1.51 %
Day's Low: $ 64.19 30 Day Perf: 4.09 %
Volume (M): 7,847 52 Wk High: $ 67.16
Volume (M$): $ 505,674 52 Wk Avg: $61.38
Open: $64.70 52 Wk Low: $54.07

 Market Capitalization (Millions $) 146,329
 Shares Outstanding (Millions) 2,271
 Employees 30,000
 Revenues (TTM) (Millions $) 42,810
 Net Income (TTM) (Millions $) -6,200
 Cash Flow (TTM) (Millions $) -4,925
 Capital Exp. (TTM) (Millions $) 740

Bristol Myers Squibb Co
Bristol-Myers Squibb Company was incorporated under the laws of the State of Delaware in August 1933 under the name Bristol-Myers Company, as successor to a New York business started in 1887. In 1989, Bristol-Myers Company changed its name to Bristol-Myers Squibb Company as a result of a merger. The Company, through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and other healthcare related products.

   Company Address: 430 E. 29th Street, 14FL New York 10016 NY
   Company Phone Number: 546-4000   Stock Exchange / Ticker: NYSE BMY
   BMY is expected to report next financial results on February 09, 2022. Next quarterly dividend pay out on August 02, 2021.

Customers Net Income fell by BMY's customers Net margin fell to 18.32 %

-4.89 %

4.31 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
JNJ        3.55% 
LLY        6.92% 
ALXN        1.04% 
ABT   -0.94%    
MRK        5.25% 
ABBV        3.81% 
• View Complete Report

Corelogic Inc

Impressive Income Growth, Sales Down Slightly

Although revenue fell in the fiscal first quarter of 2021, company managed to grow its earnings per share, income surged by 92.17 % to $0.71 per share while Sales fell by -0.76% to $422.79 millions, year on year.

From the preceding quarter, profit plummeted from $1.39 per share and Sales decreased by -3.19% from $436.73 millions.

Vector Group Ltd

Vector Group Ltd announced most recent fiscal period operating income of $90.203 millions

Vector Group Ltd showed respectable growth in the most recent fiscal period, where earnings per share more than doubled by 233.33 % year on year to $0.20 per share and Sales increased by 23.71% to $543.76 millions.

Sequentially income faded by -20% from $0.25 per share and Sales decreased by -0.74% from $547.83 millions.

National Fuel Gas Company

National Fuel Gas Company announced second quarter of 2021 earnings season operating loss of $0 millions

National Fuel Gas Company announced operating loss of $0 millions, in the second quarter of 2021 earnings season, a change from the operating shortfall of $0 millions, recorded in the same quarter a year ago.

Spx Corp

Earnings down on soft Sales

Sales and earnings fell in sympathy in the most recent fiscal period, where income fell by -14.71% to $0.58 per share and revenue by -10.37% year on year. Revenue were at $398.50 millions compared to $444.60 millions in the same quarter a year ago.

From the preceding quarter, income per share increased by 16 % from $0.50 per share and Sales advanced by 9.66 % from $363.40 millions.

Starrett L S Co

Starrett L S Co announced most recent fiscal period operating surplus of $3.85 millions

Company achieved eps growth of 455455.56 % to $410.00 in the most recent fiscal period, Sales increased by 9.89% to $54.94 millions in comparison to $50.00 millions in the prior year quarter.

compared to previous quarter eps more than doubled by 77258.49 % from $0.53 per share and Sales increased by 1.65 % from $54.05 millions.


Bristol Myers Squibb Co's Segments
 Segment    11.45 % of total Revenue
 Segment    10.1 % of total Revenue
 Segment    1.13 % of total Revenue
 Segment    4.1 % of total Revenue
 Segment    8.18 % of total Revenue
 Segment    7.86 % of total Revenue
 Segment    11.89 % of total Revenue
 Segment    45.27 % of total Revenue
Total Pharmaceuticals
 Segment    100 % of total Revenue
• View Complete Report
  Company Estimates  
  Revenue Outlook
Bristol Myers Squibb Co does not provide revenue guidance.

Earnings Outlook
Starrett L S Co does not provide earnings estimates.

Geographic Revenue Dispersion
United States 48.59 %
EMEA 22.62 %
Other 28.79 %


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

EVR's Profile

Stock Price

EVR's Financials

Business Description


Charts & Quotes

EVR's News


EVR's Competitors

Customers & Markets

Economic Indicators

EVR's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries





At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071